Skip to main navigation Skip to search Skip to main content

Magnetic Resonance imaging outcomes in the Colchicine After Stroke to Prevent Event Recurrence (MR-CASPER) trial

  • Parsons, Mark (Primary Chief Investigator (PCI))
  • Brodtmann, Amy (Chief Investigator (CI))
  • Bivard, Andrew (Chief Investigator (CI))
  • Keech, Anthony (Chief Investigator (CI))
  • Vagal, Achala (Chief Investigator (CI))
  • Churilov, Leonid (Chief Investigator (CI))
  • Patel, Sanjay (Chief Investigator (CI))
  • Parizel, Paul Maria (Chief Investigator (CI))
  • Butcher, Ken (Chief Investigator (CI))
  • Campbell, Bruce Charles Vivian (Chief Investigator (CI))
  • Blair, Christopher (Associate Investigator (AI))
  • Gao, Lan (Associate Investigator (AI))
  • Murphy, Lisa (Associate Investigator (AI))
  • O'Brien, Kieran (Associate Investigator (AI))
  • Kleinig, Timothy John (Associate Investigator (AI))
  • Anderson, Craig Stuart (Associate Investigator (AI))
  • Khlif, Mohamed (Associate Investigator (AI))
  • Garcia-Esperon, Carlos (Associate Investigator (AI))
  • Easton, Damien (Associate Investigator (AI))
  • Rost, Natalia S (Associate Investigator (AI))

Project: Research

Project Details

Short titleMR-CASPER
AcronymMR-CASPER
StatusActive
Effective start/end date1/07/22 → 1/07/27

Keywords

  • stroke
  • colchicine
  • clinical trial
  • magnetic resonance imaging (MRI)
  • post-stroke dementia
  • ischaemic stroke
  • neuroinflammation
  • cognition